Out-patient Discharge Management After General Intravenous Anesthesia

Evaluation Clinical Trial

Official title:

Out-patient Discharge Management After General Intravenous Anesthesia

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT05609383
• Other study ID #: 2021-0125
• Status: Withdrawn
• Start date: October 20, 2022
• Est. completion date: December 30, 2023

Study information

• Verified date: October 2022
• Source: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The lower limit of time for postoperative observation and discharge criteria for diagnostic or operational tests program in outpatient under general intervenous anesthesia/sedation

Description:

When is it considered safe for an outpatient to leave after a advanced procedure of general anesthesia/sedation

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 30, 2023
• Est. primary completion date: June 30, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients aged from 18 years with American Society of Anesthesiologists (ASA) physical status I to II were selected. The adaptation and contraindications of the Chinese expert consensus on sedation/anesthesia in digestive endoscopy will be used

Exclusion Criteria:

• The inclusion criteria were the patient underwent general anesthesia with endotracheal intubation or patients with systemic comorbidities or unable to walk independently or those who suffered from severe adverse events that required in-hospital observation after diagnosis and treatment or the patients with no available assistance after discharge or the emergency endoscopy patients

Related Conditions & MeSH terms

• Evaluation
• Outpatient Surgery

Intervention

Other:
• assessment
An exit evaluation was initiated immediately upon recovery from anesthesia

Locations

Country	Name	City	State
China	Outpatient Department of the Second Affiliated Hospital of Zhejiang University School of Medicine	Hangzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	time of discharge	From the time the patient enters the resuscitation room at the end of the session until the patient leaves the resuscitation room	mo more than 60 mintues
Secondary	Adverse events	Adverse reactions (Nausea, vomiting, pain, bleeding, fatigue, dizziness, or readmission for any related reason )	24 hours after surgery